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Abstract: Toluene is a widely used solvent in
different industrial areas and has a depressant
effect on the central nervous system. In
medicolegal cases, for the possible influence
of toluene on actions or conditions prior to
death, a reliable indicator of exposure must be
precisely investigated. We developed an
appropriate method for toluene analysis and
investigate the blood-urine toluene levels and
urinary ortho-cresol levels in toluene-exposed
workers. Blood and urine toluene levels from
50 male subjects were detected by Gas
Chromatography-FID (GC-FID) using the
head-space method, and urinary o-cresol
levels, a metabolite of toluene, were analyzed
by GC. The significance of difference of ocresol/creatinine levels was evaluated by the
nonparametric statistics Kruskal-Wallis One
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Introduction
Toluene (methyl benzene) is a widely used organic
solvent in the printing, painting, automotive, shoemaking
and pharmaceutical industries. It is also the common
substance in glue and thinner sniffed by drug abusers (13).
Toluene is a central nervous system (CNS) depressant.
The acute effects of toluene are similar to those of alcohol
intoxication (2,4,5). Acute poisoning includes initial
excitement or euphoria followed by CNS depression with
headaches, dizziness, blurred vision, and ataxia. In severe
cases, coma, convulsion and death from respiratory
failure occur. Chronic poisoning has resulted mainly in
nervous system disorders, and renal and hepatic damage
(6-8). Toluene can be absorbed into the blood flow from
the lungs and the gastrointestinal tract and through the
skin and mucosa. Fat-rich tissues such as brain and liver
serve as the most extensive reservoir for toluene (2).
Occupational exposure to toluene mainly occurs as fume
inhalation when the compound is used as a solvent (9).
More than 80% of absorbed toluene is metabolized
by mix-oxidase enzyme systems to benzoic and hippuric

Way Anova, and correlation and regression
statistics were determined by Pearson
Correlation of bivariant analysis. The toluene
concentrations in blood ranged from 0.07 to
2.12 mg/g. Urinary o-cresol levels were not
correlated significantly with blood or urine
toluene levels. There was no significant
difference for ortho-cresol/creatinine levels
between the control and worker groups. It is
concluded that for medicolegal purposes,
urine toluene and urinary o-cresol levels are
not reliable markers, and direct toluene
analysis in blood must be preferrred in
toluene exposure.
Key Words: forensic toxicology, toluene,
toluene exposure, toluene abuse, ortho-cresol

acid before excretion into the urine. Some absorbed
toluene (0.4 - 1.1%) is hydroxylated and excreted as a
mixture of ortho-, para- and meta-cresol (9,10).
Among the metabolites, hippuric acid is a traditional
biomarker in the biological monitoring of occupational
exposure to toluene (11,12) but it is known that p-cresol
and hippuric acid rates are obscured by endogeneous and
dietary sources (10). Nise also found an association
between alcohol consumption and hippuric acid excretion
in toluene-exposed printers. Recently it is supposed that
o-cresol is the least influenced by background
contribution (10,13,14).
Cases in which toluene has forensic relevance can be
divided into three groups: traffic violations or accidents
where the driver’s impairment was caused by toluene
inhalation, crimes (usually violent) where toluene may be
related to the behaviour of the individual or individuals
involved, and cases in which the presence of toluene in
blood or tissue has some relationship to the cause of
death or the general health of the person (15).
Driving and working under the influence of toluene
must be evaluated regarding the possibility of driving
415
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impairment/workplace accidents in legal cases. A case of
accidental death due to falling from a height with acute
sub-lethal toluene poisoning during painting was reported
(4,16).
Recently toluene abuse has become a social problem in
Turkey and analysis of this substance is not performed
effectively yet. This study was undertaken to develop an
appropriate method for toluene analysis and to determine
a reliable indicator(s) in toluene exposure for medicolegal
purposes. Blood-urine toluene levels were analyzed by a
Gas Chromatography-Flame Ionization Detector (GC-FID)
with head-space sampling, and urinary ortho-cresol levels
were analyzed by GC in toluene-exposed subjects.

Materials and Methods
Subjects
In this study, 50 male subjects, 41 workers exposed
to toluene from three different industrial areas and 9
healthy male subjects for control, were selected. Group 1:
15 male workers from the painting sector of the
automotive industry (age 20-60 years, weight 56-115 kg
and working period 5-35 years), Group 2: 10 male
workers who repair car hoods (age 22-49 years, weight
64-85 kg and working period 3-27 years), Group 3: 16
male workers from the shoemaking industry (age 12-48
years, weight 45-70 kg and working period 2-39 years).
Blood and urine sampling time of workers was at the end
of the eight hour workshift on the sixth day of a working
week.
Urine samples could not be obtained from 2 and 1
workers in groups 1 and 3 respectively. A blood sample
could not be obtained from 1 subject in group 2.
The control group consisted of 9 healthy nonexposed
male subjects (age 23-27 years, weight 70-85 kg).
Biological specimens
Blood samples were extracted from the cubital vein of
the workers into 9 mL vacutainer tubes containing
sodium citrate (Merck) as the anticoagulant. After
pouring 5 mL of blood into a 10 mL glass head space vial
(with Teflon septa and aluminum cap-HP), the vial was
capped immediately and kept frozen at –20ºC until
analysis (15).
Urine samples from each worker were collected in 20
mL screw-capped bottles containing 60 mg sodium
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flouride (Riedel) as the preservative. After pouring 5 mL
of urine into a 10 mL glass head space vial, the vial was
capped immediately and kept frozen at –20ºC until
analysis. Urine samples left in the bottle were kept for
urinary o-cresol analysis under the same storage
conditions (10,17).
Toluene analysis
Toluene standards were prepared in 25 mL screwcapped glass tubes using human blood obtained from a
blood bank. Calculated volumes of toluene (Merck, HPLC
Grade) were added to known volumes of ice-cold blood
using a Hamilton microsyringe (HP). We started with the
highest concentration quantity of toluene (50 µg/g) and,
by dilution with blood each time, the lowest concentration
was reached (0.780 µg/g). Only a small volume of air (<
5%) was allowed above the blood. The tubes were
sonicated (Ultrasonic LC 30) at 4ºC for 1 h. Blood was
poured into 10 mL vials and capped immediately. Two
vials for each concentration were prepared and stored at
-20ºC. Seven standard concentrations were used: 0.780,
1.560, 3.125, 6.250, 12.5, 25 and 50 µg/g. For each
concentration, five injections were performed.
Instruments: Hewlett Packard HP 6890 GC system
equipped with a flame ionization detector (FID). The
column used was Supelcowax 10, 2-5301 (30.0 m x
530.00 µm i.d., film thickness 1.00 µm). The carrier gas
was helium, 5.4 mL/min, column temperature was 80ºC,
detector temperature was 250ºC, inlet temperature was
80ºC and split ratio was 3:1.
Biological samples kept at -20ºC were left to thaw at
room temperature over 20 min. Then the samples were
heated at 50ºC for 20 min and 0.5 mL of head space air
was injected into a gas chromatograph with a warmed 5
mL glass gas syringe (Supelco SGE Syringe, 5 MAX-HSV,
2-3984) (17). For each individual, duplicate analysis was
performed.
O-cresol analysis
O-cresol (Sigma) standards, 0.625, 1.250, 2.5 and 5
µg/mL prepared in carbon disulfide (Sigma, HPLC Grade),
were spiked with 25 mg/L 3,5-xylenol (Merck) as an
internal standard. For each concentration, triplicate
injections were performed.
Instruments: GC-FID, column used was Supelcowax
10. The carrier gas was helium, 6.2 mL/min, column
temperature was programmed as 2 min hold at 100ºC,
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8ºC/ min from 100-200ºC, 5 min hold at 200ºC. Detector
temperature was 250ºC, inlet temperature was 210ºC
and the split ratio was 50:1.
After warming the urine samples to room
temperature, 0.5 mL 15% HCl (Merck) was added to 1
mL of urine and the mixture was heated at 100ºC in a
water bath (Kottermann) for 1 h. After cooling the urine
samples to room temperature under tap water, 0.1 mL of
3,5-xylenol (25 mg/L water) was added as an internal
standard and the resulting solution was mixed by shaking
for 10 min with 2 mL of carbon disulfide, and centrifuged
at 2000 rpm for 3 min. The organic phase of the extract
was treated with 0.5 g of anhydrous sodium sulfate
(Merck) and centrifuged at 2000 rpm for 10 min again.
The carbon disulfide solution was evaporated to 100 µL
at 30ºC under a stream of nitrogen gas in an evaporator
and 1 µL was injected into GC (10). Ortho-cresol
concentrations were corrected for urinary flow by
dividing by the urinary creatinine concentrations.
Ethics
The investigation conformed to the principles outlined
in the Declaration of Helsinki.
Statistical Analysis
The significance of difference of o-cresol/creatinine
levels among the groups was evaluated by the
nonparametric statistics Kruskal-Wallis One-way Anova of
SPSS (Statistical Packages for Social Sciences).
Correlation and regression statistics were determined
between blood, urine toluene and o-cresol/creatinine
levels by Pearson Correlation of bivariant analysis.

Group

I (n=15)
II (n=10)
III (n=16)
Control (n=9)

Results
Under the GC conditions described, the retention
times (RT) of toluene , o-cresol and 3,5-xylenol were
3.45, 13.59 and 15.78 min respectively. The recovery of
o-cresol ranged from 84 to 96%. The toluene calibration
curve was linear up to 6.250 µg/g concentrations, with a
correlation coefficient of 0.998. The detection limit for
toluene was 0.02 µg/g. The coefficient of variation (CV)
of the method for the multiple runs on the same day was
3.8%. For o-cresol, a linear calibration curve was
obtained with a correlation coefficient of 0.997. The
detection limit of o-cresol was 0.01 µg/mL.
The minimum and maximum levels of blood toluene,
urine toluene and urinary o-cresol/creatinine levels for
three worker groups and the control group are presented
in the Table. In all the study groups toluene was detected
in the blood. The toluene concentrations in blood ranged
from 0.07 to 2.12 µg/g. On the other hand, no toluene
was detected in the control blood and urine samples.
Toluene was not detected in the fourth and seventh urine
samples of groups I and II respectively.
No correlation was found between blood toluene and
urine toluene levels in workers exposed to toluene. Ocresol was detected in all urine samples (except one) of
the control group and the levels of o-cresol/creatinine
were not significantly different from those of the exposed
subjects. In addition, no correlation was found between
o-cresol/creatinine and blood/urine toluene levels.

Blood toluene*
min-max

Urine toluene*
min-max

O-cresol/creatinine•
min-max

0.09-2.12

0.02-0.14

0.17-0.97

n=15

n=13

n=13

0.09-0.31

0.02-0.09

0.04-0.89

n=9

n=10

n=10

0.07-0.30

0.03-0.23

0.01-0.72

n=16

n=14

n=14

ND

ND

0.03-0.76

Table

Blood toluene, urine toluene and
urinary ortho-cresol/creatinine
concentrations of three worker
groups and the control group.

n=8
*: µg/g
•: mg/g
ND: Not Detected
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Discussion
In our study, blood toluene concentrations ranged
from 0.07 to 2.12 µg/g. This concentration range was
consistent with the range given by Miyazaki et al. (17), in
which mild intoxication findings begin, and so this range
might possess risk. For medicolegal purposes, it is very
important to develop a reliable toluene exposure indicator
in individuals who are exposed to toluene, regarding the
occurrence of traffic violations or accidents, workplace
accidents, solvent abuse and death (5,15). The presence
of toluene in all workers and the possibility of it becoming
part of legal cases at any moment must be taken into
consideration. Blood specimen collection for toluene
analysis is another important legal fact that must be taken
into account, because losses of toluene in blood can be
caused by handling and storage conditions, and sample
preparation and sampling (15).
In two subjects, urine toluene was not detected and
for all the subjects there was no correlation between
blood and urine toluene concentrations. Therefore the
results of our study showed that urine toluene levels
cannot be used as a reliable indicator in toluene exposure.
However, Kawai et al. (18) reported that urine toluene is
a better marker of exposure than urinary metabolites.
Some studies suggest that the determination of
urinary o-cresol excretion represents a diagnostically
specific and sensitive parameter for the estimation of an
individual toluene uptake (10,19,20). However, in the
present study we found no correlation between

blood/urine toluene levels and urinary o-cresol/creatinine
levels. Furthermore, the results of our study showed that
the o-cresol/creatinine levels of the control group were
not significantly different from those of the workers.
Inoue et al. (21) have pointed out that urinary o-cresol
levels were significantly reduced by smoking, drinking
and the two habits combined and they cannot be
considered a reliable indicator of exposure to toluene.
We concluded that, in medicolegal cases, toluene
analysis should be performed effectively and direct
toluene analysis in blood must be preferred to urine
toluene and urinary o-cresol analysis.
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